Free Access
Vet. Res.
Volume 37, Number 1, January-February 2006
Page(s) 145 - 154
Published online 13 December 2005
How to cite this article Vet. Res. (2006) 145-154
References of Vet. Res. 37 (2006) 145-154
  1. Balaban N.Q., Merrin J., Chait R., Kowalik L., Leibler S., Bacterial persistence as a phenotypic switch, Science 305 (2004) 1622-1625 [CrossRef].
  2. Bébéar C., Robertson J.A., Determination of minimal inhibitory concentrations, in: Tully J.G., Razin S. (Eds.), Molecular and diagnostic procedures in mycoplasmology, Vol. II: Diagnostic procedures, Academic Press, New York, 1996, pp. 189-197.
  3. Bébéar C.M., Renaudin H., Charron A., Bové J.M., Bébéar C., Renaudin J., Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro, Antimicrob. Agents Chemother. 42 (1997) 2304-2311.
  4. Bébéar C.M., Charron A., Bové J.M., Bébéar C., Renaudin J., Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of Mycoplasma hominis, Antimicrob. Agents Chemother. 42 (1998) 2024-2031 [PubMed].
  5. Bébéar C.M., Renaudin J., Charron A., Renaudin H., de Barbeyrac B., Schaeverbeke T., Bébéar C., Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis, Antimicrob. Agents Chemother. 43 (1999) 954-956 [PubMed].
  6. Bébéar C.M., Renaudin H., Charron A., Gruson D., Lefrançois M., Bébéar C., In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized, Antimicrob. Agents Chemother. 44 (2000) 2557-2560 [CrossRef] [PubMed].
  7. Bradbury J.M., Yavari C.A., Giles C.J., In vitro evaluation of various antimicrobials against Mycoplasma gallisepticum and Mycoplasma synoviae by the micro-broth method, and comparison with a commercially-prepared test system, Avian Pathol. 23 (1994) 105-115.
  8. Chambaud I., Heilig R., Ferris S., Barbe V., Samson D., Galisson F., Moszer I., Dybvig K., Wroblewski H., Viari A., Rocha E.P., Blanchard A., The complete genome sequence of the murine respiratory pathogen Mycoplasma pulmonis, Nucleic Acids Res. 29 (2001) 2145-2153 [CrossRef] [PubMed].
  9. Combet C., Blanchet C., Geourjon C., Deléage G., NPS@: Network Protein Sequence Analysis, TIBS 25 (2000) 147-150.
  10. Dallo S.F., Baseman J.B., Intracellular DNA replication and long-term survival of pathogenic mycoplasmas, Microb. Pathog. 29 (2000) 301-309 [PubMed].
  11. Ferrero L., Cameron B., Manse B., Lagneaux D., Crouzet J., Famechon A., Blanche F., Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones, Mol. Microbiol. 13 (1994) 641-653 [PubMed].
  12. Forsyth M.H., Sayed A.S., Geary S.J., Sequence and transcriptional analysis of the genes encoding the class-II topoisomerase of Mycoplasma gallisepticum, Gene 163 (1995) 161-162 [CrossRef] [PubMed].
  13. Freundt E.A., Culture media for classic mycoplasmas, in: Tully J.G., Razin S. (Eds.), Methods in mycoplasmology, Vol. I. Mycoplasma characterization, Academic Press, New York, 1983, pp. 127-135.
  14. Frey M.L., Hanson R.P., Anderson D.P., A medium for isolation of avian mycoplasmas, Am. J. Vet. Res. 29 (1968) 2163-2171 [PubMed].
  15. Gautier-Bouchardon A.V., Reinhardt A.K., Kobisch M., Kempf I., In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae, Vet. Microbiol. 88 (2002) 47-58 [CrossRef] [PubMed].
  16. Hirose K., Kawasaki Y., Kotani K., Abiko K., Sato H., Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance, J. Vet. Med. B Infect. Dis. Vet. Public Health 51 (2004) 169-175 [PubMed].
  17. Hooper D.C., Mechanisms of fluoroquinolone resistance, Drug Resist. Updat. 2 (1999) 38-55 [PubMed].
  18. Kellog D.E., Kwok S., Detection of human immunodeficiency virus, in: Innis M.A., Gelfand D.H., Sninsky J.J., White T.J. (Eds.), PCR protocols: a guide to methods and applications, Academic Press, San Diego, 1990, pp. 339-343.
  19. Kempf I., Gesbert F., Comparison of serological tests for detection of Mycoplasma gallisepticum antibodies in eggs and chicks hatched from experimentally infected hens, Vet. Microbiol. 60 (1998) 207-213 [CrossRef] [PubMed].
  20. Kempf I., Ollivier C., L'hospitalier R., Guittet M., Bennejean G., Concentrations minimales inhibitrices de 13 antibiotiques vis-à-vis de 21 souches de mycoplasmes des volailles, Le Point Vétérinaire 20 (1988) 83-88.
  21. Keren I., Kaldalu N., Spoering A., Wang Y., Lewis K., Persister cells and tolerance to antimicrobials, FEMS Microbiol. Lett. 230 (2004) 13-18 [PubMed].
  22. Kleven S.H., Mycoplasma synoviae infection, in: Barnes H.J., Glisson J.R., Fadly A.M., McDougald L.R., Saif Y.M. (Eds.), Diseases of Poultry, 11th ed., Iowa State University Press, Ames, Iowa, 2003, pp. 756-766.
  23. Knoll U., Glunder G., Kietzmann M., Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens, J. Vet. Pharmacol. Ther. 22 (1999) 239-246 [PubMed].
  24. Ladefoged S.A., Christiansen G., Sequencing analysis reveals a unique gene organization in the gyrB region of Mycoplasma hominis, J. Bacteriol. 176 (1994) 5835-5842 [PubMed].
  25. Marois C., Dufour-Gesbert F., Kempf I., Detection of Mycoplasma synoviae in poultry environment samples by culture and polymerase chain reaction, Vet. Microbiol. 73 (2000) 311-318 [CrossRef] [PubMed].
  26. Maxwell A., Critchlow S.E., Chapter 4: Mode of action, in: Kuhlmann J., Dalhoff A., Zeiler H.J. (Eds.), Handbook of experimental pharmacology: Quinolone antibacterials, Springer-Verlag, Berlin, 1998, pp. 120-166.
  27. Much P., Winner F., Stipkovits L., Rosengarten R., Citti C., Mycoplasma gallisepticum: influence of cell invasiveness on the outcome of experimental infection in chickens, FEMS Immunol. Med. Microbiol. 34 (2002) 181-186 [PubMed].
  28. Papazisi L., Gorton T.S., Kutish G., Markham P.F., Browning G.F., Nguyen D.K., Swartzell S., Madan A., Mahairas G., Geary S.J., The complete genome sequence of the avian pathogen Mycoplasma gallisepticum strain R(low), Microbiology 149 (2003) 2307-2316 [CrossRef] [PubMed].
  29. Piddock L.J.V., Mechanisms of fluoroquinolone resistance: an update 1994-1998, Drugs 2 (1999) 11-18 [CrossRef].
  30. Raherison S., Gonzales P., Renaudin H., Increased expression of two multidrug transporter-like genes is associated with ethidium bromide and ciprofloxacin resistance in Mycoplasma hominis, Antimicrob. Agents Chemother. 49 (2005) 421-424 [CrossRef] [PubMed].
  31. Reinhardt A.K., Bébéar C.M., Kobisch M., Kempf I., Gautier-Bouchardon A.V., Characterization of mutations in DNA gyrase and topoisomerase IV involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro, Antimicrob. Agents Chemother. 46 (2002) 590-593 [CrossRef] [PubMed].
  32. Reinhardt A.K., Kempf I., Kobisch M., Gautier-Bouchardon A.V., Fluoroquinolone resistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerases on resistance level, J. Antimicrob. Chemother. 50 (2002) 589-592 [CrossRef] [PubMed].
  33. Reinhardt A.K., Gautier-Bouchardon A.V., Gicquel-Bruneau M., Kobisch M., Kempf I., Persistence of Mycoplasma gallisepticum in chickens after treatment with enrofloxacin, without resistance development, Vet. Microbiol. 106 (2005) 129-137 [CrossRef] [PubMed].
  34. SAS Institute, SAS/STAT user's guide, version 8, SAS Institute Inc., Cary, NC, 1999.
  35. Stanley W.A., Hofacre C.L., Speksnijder G., Kleven S.H., Aggrey S.E., Monitoring Mycoplasma gallisepticum and Mycoplasma synoviae infection in breeder chickens after treatment with enrofloxacin, Avian Dis. 45 (2001) 534-539 [CrossRef] [PubMed].
  36. Sumano L.H., Ocampo C.L., Brumbaugh G.W., Lizarraga R.E., Effectiveness of two fluoroquinolones for the treatment of chronic respiratory disease outbreak in broilers, Br. Poult. Sci. 39 (1998) 42-46 [CrossRef] [PubMed].
  37. Wang C., Ewing M., Aarabi S.Y., In vitro susceptibility of avian mycoplasmas to enrofloxacin, sarafloxacin, tylosin and oxytetracycline, Avian Dis. 45 (2001) 456-460 [CrossRef] [PubMed].
  38. Wang T., Tanaka M., Sato K., Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains, Antimicrob. Agents Chemother. 42 (1998) 236-240 [PubMed].
  39. Winner F., Rosengarten R., Citti C., In vitro cell invasion of Mycoplasma gallisepticum, Infect. Immun. 68 (2000) 4238-4244 [CrossRef] [PubMed].
  40. Yokoyama K., Makino K., Kubota Y., Watanabe M., Kimura S., Yutsudo C.H., Kurokawa K., Ishii K., Hattori M., Abe H., Iida T., Yamamoto K., Hayashi T., Yasunaga T., Honda T., Sasakawa C., Shinagawa H., Complete nucleotide sequence of the prophage VT1-Sakai carrying the Shiga toxin 1 genes of the enterohemorrhagic Escherichia coli O157:H7 strain derived from the Sakai outbreak, Gene 258 (2000) 127-139 [CrossRef] [PubMed].